Kyverna Therapeutics Says FDA Grants Regenerative Medicine Advanced Therapy Designation to Autoimmune Disorder Drug
Kyverna Therapeutics Says FDA Grants Regenerative Medicine Advanced Therapy Designation to Autoimmune Disorder Drug
Kyverna Therapeutics表示，FDA授予其针对自身免疫性疾病的药物再生医学先进疗法认定。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册